PUBLICATIONS
PAPERS
Sunkureddi P, Nguyen-Oghalai T, Jarvis J, Karnath B. Clinical Signs of Dermatomyositis. Hospital Physician. April 2005:41(3);41-44 (Dematomyositis.pdf)
Sunkureddi P, Kumar S, Baethge B. Photo Dx: Persistent Pain and Swelling after an Insect Bite.The Journal of Musculoskeletal Medicine. August 2005:22(8);417-419
Sunkureddi P, Baethge B. et al. Eosinophilic enteritis associated with systemic lupus erythematosus. Southern Medical Journal. October 2005;98(10):1049-52 (Lupus and Eosinophilic Enteritis.pdf)
Sunkureddi P, Baethge B. Eosinophilic gastroenteritis associated with systemic Lupus erythematosus. The Journal of Clinical Gastroenterology. (Letter to the Editor). Oct 2005; 39(9):838-9
Sunkureddi P, Gonzalez EB, Washington R et al. A 39 year old man with chest pain: Cardiovascular manifestations of systemic lupus erythematosus. Cleveland Clinic Journal of Medicine. November 2005:72(11);1050-56 (Lupus and CV Disease.pdf)
Sunkureddi P, Karnath B, Nguyen-Oghalai T. Clinical signs of Gout. Hospital Physician. January 2006:42(1);39-42,47 (Gout.pdf)
Sunkureddi P, Contreras J, Eisenberg M,. Photo Dx: Hand pain and swelling in a 63 year old woman. The Journal of Musculoskeletal Medicine. April 2006:23(4);282-284
Karnath B, Sunkureddi P. Extra-intestinal manifestations of hepatogastrointestinal disease. Hospital Physician. July 2006:42(7);51-56 (GI Disease.pdf)
Eisenberg M, Sunkureddi P, McNearney T, Gonzalez EB. Unusual occurrence of Renal Cell Carcinoma diagnosed in two young Hispanic patients with diffuse systemic sclerosis. Journal of Clinical Rheumatology. December 2007: 13(6);363-364
Kumar S, Pappalardo E, Gonzales EB, Sunkureddi P, Pierangeli S. Isolated Elevation of IgA Anti-Beta 2Glycoprotein I Antibodies with Manifestations of Antiphospholipid Syndrome (APS): A case series of six patients.Lupus. 2009;18(11):1011-4
ABSTRACTS
Gonzalez EB, McNearney TM, Wollaston DE, Sunkureddi P, Lau DT. Prevalence of Hepatitis C infection in an autoantibody-positive population from a university-based rheumatology clinic. Arthritis & Rheumatism 2005;52(9):S96.
Sunkureddi P, McNearney TM, Vasquez VT, Gonzalez, EB. Race/Ethnicity differences in anti-CCP antibody in patients with suspected rheumatoid arthritis. Arthritis & Rheumatism 2005;52(12):4095
Gonzalez EB, McNearney TM, Sunkureddi P. Higher anti-ccp anibody titers and test sensitivity observed in non-caucasians with rheumatoid arthritis. EULAR, Barcelona, June 2007
Kumar S, Gonzalez EB, Najam S, Pappalardo E, McNearney T, Sunkureddi P, Pierangeli SS. Isolated Elevation of IgA anti-Beta 2 Glycoprotein I antibodies with manifestations of anti-phospholipid antibody syndrome: A case series of five patients. Presented at the 6th International Congress on Autoimmunity, Porto, Portugal, September 2008
Rezazedeh B, McNearney TM, Gonzalez EB, Sunkureddi P. Race/Ethnicity is more strongly associated with anti-ccp antibody titers than smoking in rheumatoid arthritis. American College of Rheumatology Annual Scientific Meeting, San Francisco, CA 2008
Martinez LA, Valenzuela R, Seif AM, Papalardo E, Vilá LM, Najam S, McNearney TA, Gonzalez EB, Sunkureddi P, Binder WL, Reveille JD, Norman G, Shums Z, Alarcon GS and Pierangeli SS. Do Clinically Relevant IgA-Anti-B2glycoprotein I (anti-B2GPI) Antibodies Bind to Domain IV/V of β2GPI: American College of Rheumatology Annual Scientific Meeting, Philadelphia, PA 2009
CLINICAL TRIALS
Sub-Investigator, " A phase 4, Multicenter, Open-label, Assessor-blinded, Switch Study of the Efficacy and Safety of Infliximab (REMICADE) in Patients with Active Rheumatoid Arthritis who are responding inadequately to Etanercept (ENBREL) or Adalimumab (HUMIRA)". Phillip Waller, MD and Accurate Clinical Research; Ongoing
Sub-Investigator, " A Phase IIIb, multi-center study with a 12-week double-blind, placebo controlled, randomized period followed by an open label, extension phase to evaluate the safety and efficacy of certolizumab pegol administered to patients with active rheumatoid arthritis". Phillip Waller, MD and Accurate Clinical Research, Ongoing.
Co-Investigator, " A Phase III, multi-center, open label study to evaluate the efficacy, tolerability and safety of Abatacept in subjects with active rheumatoid arthritis on background non-biologic DMARDs who have an inadequate response to anti-TNF therapy and have limited therapeutic options". UTMB July 2005-Aug 2006
Primary Investigator, “Application of Methotrexate Optimization in Rheumatoid Arthritis”, 2009
Primary Investigator- A prospective, multi-center, observational study to assess the impact of Enbrel treatment on work imparment in employed moderate to severe rheumatoid arthritis patients receiving care in community based practices-Ongoing
|
